Maxim analyst Jason McCarthy downgraded Cero Therapeutics (CERO) to Hold from Buy.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERO:
- Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
- Why Is CERo Therapeutics Stock Down 80% Today?
- CERo Therapeutics Faces Nasdaq Delisting Suspension
- Cero Therapeutics discloses Nasdaq Panel listing determination
- Cero Therapeutics’ Innovative AML Treatment Study: A Potential Game-Changer?